Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 3/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL29739052 | 0.97 | TUBB1 (0.42) | TUBB1LMNAMAPK1HTTRAB9A | |
| Bromide SCHEMBL29189119 | 0.95 | TUBB1 (0.41) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL167017 | 0.80 | TUBB1 (0.41) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL8885005 | 0.80 | TUBB1 (0.41) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL11160603 | 0.80 | ACHE (0.41) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL7976367 | 0.80 | TUBB1 (0.41) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL20149289 | 0.80 | MAPT (0.39) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL28977384 | 0.80 | TUBB1 (0.39) | TUBB1LMNAMAPK1HTTRAB9A | |
| SCHEMBL24436695 | 0.78 | PTGS2 (0.44) | TUBB1LMNACYP3A4MAPTPTGS2 | |
| SCHEMBL9678363 | 0.78 | TUBB1 (0.40) | TUBB1LMNAMAPK1HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114671762-B | Fluorine-containing bi-xylylene methacrylate cross-linking agent and preparation method thereof | 长春市兆兴新材料技术有限责任公司 | 2024-03-19 | — | — | CN | claimed |
| CN-114671762-A | Fluorine-containing biphenyl dimethacrylate crosslinking agent and preparation method thereof | 长春市兆兴新材料技术有限责任公司 | 2022-06-28 | — | — | CN | claimed |
| EP-0488861-A1 | Process for the preparation of alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1992-06-03 | — | — | EP | claimed |
| US-12559454-B2 | Benzenesulfonamide derivatives and uses thereof | 2692372 ONTARIO, INC. (CA) | 2026-02-24 | — | — | US | disclosed |
| CN-119500004-A | Production system of oxyfluoro cyclic ester | 江西省驰邦药业有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20240092756-A1 | METHODS AND COMPOSITION FOR KRAS MODIFICATIONS | DUNAD THERAPEUTICS LTD. (GB) | 2024-03-21 | — | — | US | disclosed |
| CN-114671762-B | Fluorine-containing bi-xylylene methacrylate cross-linking agent and preparation method thereof | 长春市兆兴新材料技术有限责任公司 | 2024-03-19 | — | — | CN | disclosed |
| US-20230359119-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-11780935-B2 | Mutant antibodies and conjugation thereof | PFIZER HEALTHCARE IRELAND (IE) | 2023-10-10 | — | — | US | disclosed |
| EP-4247787-A2 | METHODS AND COMPOSITION FOR KRAS MODIFICATIONS | 2692372 Ontario, Inc. (CA) | 2023-09-27 | — | — | EP | disclosed |
| CN-116745264-A | Methods and compositions for KRAS modification | 2692372安大略公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2022075383-A1 | ESTER COMPOUND AND RESIN COMPOSITION | 味の素株式会社 | 2022-04-14 | — | — | WO | disclosed |
| WO-2021099842-A1 | PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO INC. (CA) | 2021-05-27 | — | — | WO | disclosed |
| US-20210147576-A1 | MUTANT ANTIBODIES AND CONJUGATION THEREOF | PFIZER HEALTHCARE IRELAND (IE) | 2021-05-20 | — | — | US | disclosed |
| WO-2021009568-A1 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO, INC. (CA) | 2021-01-21 | — | — | WO | disclosed |
| WO-2019149116-A1 | METHOD FOR PREPARING CONJUGATE | 四川科伦博泰生物医药股份有限公司 | 2019-08-08 | — | — | WO | disclosed |
| WO-2013105013-A1 | MUTANT ANTIBODIES AND CONJUGATION THEREOF | COVX TECHNOLOGIES IRELAND LIMITED (IE) | 2013-07-18 | — | — | WO | disclosed |
| WO-2012007896-A1 | MULTIFUNCTIONAL ANTIBODY CONJUGATES | COVX TECHNOLOGIES IRELAND, LTD. (IE) | 2012-01-19 | — | — | WO | disclosed |
| JP-2000156243-A | NONAQUEOUS ELECTROLYTE BATTERY | SONY CORP | 2000-06-06 | — | — | JP | disclosed |
| EP-0488861-A1 | Process for the preparation of alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1992-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092756-A1 | METHODS AND COMPOSITION FOR KRAS MODIFICATIONS | KRAS, NRAS, HRAS | TUBB1 3278/4885LMNA 1904/4885MAPK1 1706/4885 |
| US-20210147576-A1 | MUTANT ANTIBODIES AND CONJUGATION THEREOF | IGLV6-57, IGSF11, F13B | TUBB1 360/4885LMNA 752/4885MAPK1 4397/4885 |
| US-11780935-B2 | Mutant antibodies and conjugation thereof | IGLV6-57, IGSF11, F13B | TUBB1 365/4885LMNA 737/4885MAPK1 4386/4885 |
| US-12559454-B2 | Benzenesulfonamide derivatives and uses thereof | NR2E1, NR2C2, NR3C1 | TUBB1 2124/4885LMNA 1384/4885MAPK1 3317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.